Sandbox: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 3: | Line 3: | ||
[[Sandbox#Antiretroviral drug toxicities and quality of life|testing]] | [[Sandbox#Antiretroviral drug toxicities and quality of life|testing]] | ||
#'''Antiretroviral drug toxicities and quality of life''' | #'''===Antiretroviral drug toxicities and quality of life===''' | ||
## PI | ## PI | ||
Earlier initiation of ART extends exposure to ARV agents by several years. The D:A:D study found an increased incidence of CVD associated with cumulative exposure to some drugs in the [[nucleoside reverse transcriptase inhibitor]] (NRTI) and [[PI]] drug classes. | Earlier initiation of ART extends exposure to ARV agents by several years. The D:A:D study found an increased incidence of CVD associated with cumulative exposure to some drugs in the [[nucleoside reverse transcriptase inhibitor]] (NRTI) and [[PI]] drug classes. | ||
Revision as of 14:02, 23 May 2012
- ===Antiretroviral drug toxicities and quality of life===
- PI
Earlier initiation of ART extends exposure to ARV agents by several years. The D:A:D study found an increased incidence of CVD associated with cumulative exposure to some drugs in the nucleoside reverse transcriptase inhibitor (NRTI) and PI drug classes.